
FSSAI files cases against Nestle over infant formula Biotin shortfall
The story in brief
FSSAI has filed three adjudication cases against Nestle India over three infant products found non-conforming with Biotin requirements under 2020 regulations. The regulator examined NAN Excella Pro Stage 1, Lactogen Pro 1, and a follow-up formula, with shares of Nestle India falling nearly 2% on the BSE.